相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations
D. Amadori et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Axl Kinase as a Key Target for Oncology: Focus on Small Molecule Inhibitors
Clemence Feneyrolles et al.
MOLECULAR CANCER THERAPEUTICS (2014)
AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
M. K. Asiedu et al.
ONCOGENE (2014)
Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis
Guo-Xiang Ruan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types
Francisco Ferro de Beca et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Breast cancer as a systemic disease: a view of metastasis
A. J. Redig et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Axl Mediates Acquired Resistance of Head and Neck Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Erlotinib
Keith M. Giles et al.
MOLECULAR CANCER THERAPEUTICS (2013)
First Axl inhibitor enters clinical trials
Cormac Sheridan
NATURE BIOTECHNOLOGY (2013)
The receptor tyrosine kinase Ax1 is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
J. D. Paccez et al.
ONCOGENE (2013)
Axl is essential for VEGF-A-dependent activation of PI3K/Akt
Guo-Xiang Ruan et al.
EMBO JOURNAL (2012)
Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer
Zhenfeng Zhang et al.
NATURE GENETICS (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
Vascular proliferation is increased in basal-like breast cancer
Hawa Nalwoga et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
p53 and its mutants in tumor cell migration and invasion
Patricia A. J. Muller et al.
JOURNAL OF CELL BIOLOGY (2011)
Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells
Sanaa Al Saleh et al.
PLOS ONE (2011)
Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
H. Nalwoga et al.
BRITISH JOURNAL OF CANCER (2010)
R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
Sacha J. Holland et al.
CANCER RESEARCH (2010)
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
Rachel Ma Linger et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
Christine Gjerdrum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
Y. Li et al.
ONCOGENE (2009)
Cancer of the breast: 5-year survival in a tertiary hospital in Uganda
A. Gakwaya et al.
BRITISH JOURNAL OF CANCER (2008)
Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype
David Sarrió et al.
CANCER RESEARCH (2008)
Frequency of the basal-like phenotype in African breast cancer
Hawa Nalwoga et al.
APMIS (2007)
Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
Marc Tischkowitz et al.
BMC CANCER (2007)
Differences in risk factors for breast cancer molecular subtypes in a population-based study
Xiaohong R. Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Richard M. Neve et al.
CANCER CELL (2006)
Phosphoproteomic analysis of Her2/neu signaling and inhibition
Ron Bose et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
Lisa A. Carey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Multiple roles for the receptor tyrosine kinase Axl in tumor formation
SJ Holland et al.
CANCER RESEARCH (2005)
P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation
J Paredes et al.
CLINICAL CANCER RESEARCH (2005)
Cancer survival in Kampala, Uganda
A Gondos et al.
BRITISH JOURNAL OF CANCER (2005)
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor
M Gallicchio et al.
BLOOD (2005)
African American white differences in breast carcinoma - p53 alterations and other tumor characteristics
BA Jones et al.
CANCER (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
